Vista Pharmaceuticals Ltd vs Zim Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Vista Pharmaceuticals Ltd is ₹ 7.25 as of 18 May 12:10 . The P/E Ratio of Vista Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Zim Laboratories Ltd changed from 16.1 on March 2021 to 32.1 on March 2025 . This represents a CAGR of 14.80% over 5 years The Market Cap of Vista Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Zim Laboratories Ltd changed from ₹ 117.75 crore on March 2021 to ₹ 390.78 crore on March 2025 . This represents a CAGR of 27.11% over 5 years The revenue of Vista Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Zim Laboratories Ltd for the Dec '25 is ₹ 110.36 crore as compare to the Sep '25 revenue of ₹ 90.75 crore. This represent the growth of 21.61% The ebitda of Vista Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Zim Laboratories Ltd for the Dec '25 is ₹ 14.51 crore as compare to the Sep '25 ebitda of ₹ 7.8 crore. This represent the growth of 86.03% The net profit of Vista Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Zim Laboratories Ltd changed from ₹ 0.9 crore to ₹ 4.4 crore over 7 quarters. This represents a CAGR of 147.65% The Dividend Payout of Vista Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zim Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & had obtained Certificate of Commencement of Business on February 7, 1991.
The Company is engaged in the formulation of pharmaceutical products.
It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments.
This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India. The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.
Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.

About Zim Laboratories Ltd

Zim Laboratories Limited was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in Maharashtra.
The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Mumbai.
The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India.
The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector. During the year 2019-20, ZIM Health Technologies Limited was acquired, making it a wholly owned subsidiary of the Company.
SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.

FAQs for the comparison of Vista Pharmaceuticals Ltd and Zim Laboratories Ltd

Which company has a larger market capitalization, Vista Pharmaceuticals Ltd or Zim Laboratories Ltd?

Market cap of Vista Pharmaceuticals Ltd is 44 Cr while Market cap of Zim Laboratories Ltd is 529 Cr

What are the key factors driving the stock performance of Vista Pharmaceuticals Ltd and Zim Laboratories Ltd?

The stock performance of Vista Pharmaceuticals Ltd and Zim Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Vista Pharmaceuticals Ltd and Zim Laboratories Ltd?

As of May 18, 2026, the Vista Pharmaceuticals Ltd stock price is INR ₹7.3. On the other hand, Zim Laboratories Ltd stock price is INR ₹98.9.

How do dividend payouts of Vista Pharmaceuticals Ltd and Zim Laboratories Ltd compare?

To compare the dividend payouts of Vista Pharmaceuticals Ltd and Zim Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.